Madrigal Pharmaceuticals, Inc.
(Borse Berlin : SNTA)

( )
SNTA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
-2.04%166.430.4%$267.67m
VRXValeant Pharmaceuticals International, Inc.
0.73%22.1914.1%$214.98m
PRGOPerrigo Co. Plc
-1.07%75.166.7%$102.77m
JAZZJazz Pharmaceuticals Plc
-1.28%164.952.2%$88.06m
PTLAPortola Pharmaceuticals, Inc.
-1.79%39.497.7%$77.19m
GWPHGW Pharmaceuticals PLC Sponsored ADR
4.22%158.227.6%$69.15m
SAGESAGE Therapeutics, Inc.
-5.17%155.899.6%$61.14m
MNKMallinckrodt Plc
1.37%16.3321.1%$57.77m
SUPNSupernus Pharmaceuticals, Inc.
0.73%54.956.3%$48.46m
PBHPrestige Brands Holdings, Inc.
1.48%33.663.8%$39.58m
UTHRUnited Therapeutics Corporation
0.46%105.5614.4%$38.61m
ICPTIntercept Pharmaceuticals, Inc.
-0.04%69.9621.8%$32.35m
CTLTCatalent Inc
-2.45%39.102.6%$31.42m
HZNPHorizon Pharma plc
1.39%15.317.5%$30.50m
ENDPEndo International Plc
7.23%6.388.9%$29.90m

Company Profile

Madrigal Pharmaceuticals, Inc. clinical-stage biopharmaceutical company. It focuses on the development and commercialization of novel compounds for the treatment of cardiovascular, metabolic and liver diseases. The company offers MGL-3196, an orally administered, small-molecule liver-directed ß-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Madrigal Pharmaceuticals was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA.